Psilocybin Dosing: A Complete Weight-Based Guide

Psilocybin Dosing: A Complete Weight-Based Guide

Psilocybin dosing is one of the most common and consequential questions for anyone approaching a session. The same dose that produces a mild, manageable experience for one person can produce an overwhelming experience for another. Understanding the factors that influence dose-response — body weight, individual sensitivity, species and preparation differences, set and setting — is essential for safe, intentional use.

This guide presents the standard weight-adjusted dose ranges used in harm reduction and clinical contexts. It is educational and does not constitute medical advice.

The Standard Dose Ranges

The most commonly used clinical dose in research protocols is 25mg of synthetic psilocybin — roughly equivalent to 3.5g of dried Psilocybe cubensis for an average adult. However, the "right" dose depends significantly on individual factors.

Threshold Dose: 0.5–1g dried mushrooms (or ~5–10mg psilocybin)

The minimum dose at which most people notice any effect. Characterized by:

• Mild perceptual changes (colors slightly brighter, sounds richer)
• Mild mood elevation or relaxation
• No significant alteration of consciousness
• Duration: 2–3 hours

Who it's for: First-time users testing individual sensitivity; people using microdosing transition doses.

Low Dose: 1–1.5g dried (or ~10–15mg psilocybin)

Body weight adjustment:

• 100 lbs (45 kg): 0.8–1.0g
• 130 lbs (59 kg): 1.0–1.3g
• 150 lbs (68 kg): 1.0–1.5g
• 180 lbs (82 kg): 1.2–1.5g
• 200+ lbs (91+ kg): 1.3–1.8g

Characterized by:

• Noticeable mood shift and heightened emotional sensitivity
• Mild visual enhancements (geometric patterns at eyes-closed)
• Increased introspective capacity
• No loss of connection to ordinary reality
• Duration: 3–4 hours

Who it's for: First sessions, therapeutic microdosing protocols, integration work without full-session intensity.

Moderate Dose: 2–2.5g dried (or ~20–25mg psilocybin)

Body weight adjustment:

• 100 lbs (45 kg): 1.5–2.0g
• 130 lbs (59 kg): 1.8–2.2g
• 150 lbs (68 kg): 2.0–2.5g
• 180 lbs (82 kg): 2.2–2.8g
• 200+ lbs (91+ kg): 2.5–3.0g

Characterized by:

• Significant perceptual alteration — open and closed-eye visuals
• Strong emotional and introspective effects
• Ego softening — reduced sense of the separate self
• Some dissolution of the ordinary narrative mental state
• Duration: 4–5 hours

Who it's for: People with previous experience seeking deeper work; standard therapeutic session range for many protocols.

High Dose / Full Session: 3–3.5g dried (or ~30–35mg psilocybin)

Body weight adjustment:

• 100 lbs (45 kg): 2.0–2.5g
• 130 lbs (59 kg): 2.5–3.0g
• 150 lbs (68 kg): 3.0–3.5g
• 180 lbs (82 kg): 3.2–3.8g
• 200+ lbs (91+ kg): 3.5–4.2g

Characterized by:

• Profound alteration of consciousness — significant ego dissolution
• Complex visionary or narrative experience
• Possible mystical-type experience (sense of unity, transcendence)
• Challenging emotions may surface
• Duration: 5–6 hours

Who it's for: Experienced users seeking deep therapeutic or spiritual work; the standard range for research protocols targeting mystical-type experiences. Requires appropriate set, setting, and support.

Very High Dose: 4–5g+ dried (or 40–50mg+ psilocybin)

Body weight adjustment:

• These doses scale significantly by weight and sensitivity
• Not appropriate for first or second sessions under any circumstances
• Requires extensive prior experience and appropriate preparation

Characterized by:

• Complete dissolution of ordinary consciousness possible
• "Ego death" — temporary loss of the sense of separate self
• Extremely intense visionary content
• May involve temporary inability to distinguish inner experience from external reality
• Duration: 5–7 hours

Who it's for: Experienced practitioners in appropriate settings. Not recommended without a sitter or guide and extensive personal experience at lower doses.

Critical Factors Beyond Body Weight

Body weight is a useful starting point but explains only a portion of individual dose-response variability. These factors matter as much or more:

Individual Neurobiological Sensitivity

Some people are consistently more sensitive to psilocybin than others at equivalent doses. This likely reflects variation in:

• 5-HT2A receptor density and sensitivity
• CYP2D6 enzyme activity (psilocybin is metabolized by this enzyme; rapid metabolizers may need higher doses; poor metabolizers may need lower doses)
• Baseline serotonin system state

Practical implication: Start lower and adjust based on observed response in your first sessions.

Prior Psychedelic Experience

The psychological and emotional demands of psilocybin are significant. Experienced users have developed skills — emotional regulation, trust, surrender — that allow them to work with higher doses more safely and productively than naive users.

Set and Setting

Anxiety, fear, or resistance increases the difficulty of any dose. Optimal set (calm, prepared, intentional) and setting (safe, familiar, comfortable) effectively reduce the difficulty of a given dose. The same objective dose feels much stronger in an anxious state than a calm one.

Recent Food and Water Intake

Psilocybin on an empty stomach absorbs faster and more completely. A light or empty stomach increases effective dose relative to the same amount taken with food. Many clinical protocols recommend a 4-hour fast before sessions.

Prior Tolerance

Psilocybin produces rapid tolerance via 5-HT2A receptor downregulation. Using psilocybin on consecutive days significantly reduces effect at the same dose. At least 2-3 weeks between sessions is standard; 4-6 weeks is common in therapeutic protocols to allow full receptor resensitization.

Species Potency Differences

Different mushroom species contain dramatically different psilocybin concentrations. The weight-based ranges above are calibrated for Psilocybe cubensis (the most common cultivated species):

| Species | Relative Potency vs. Cubensis | Notes | |---------|------------------------------|-------| | P. cubensis (standard) | 1× (baseline) | ~0.6–1% psilocybin by dry weight | | P. cubensis (potent strains: PE, APE) | 1.5–2× | Penis Envy strains significantly more potent | | P. azurescens | 3–4× | Average ~1.78% psilocybin; highest-potency major species | | P. semilanceata (Liberty Cap) | 1.5–2× | Small wild mushrooms; variable potency | | P. cyanescens (Wavy Caps) | 2–3× | High-potency Pacific Northwest species | | P. tampanensis (Philosopher's Stone sclerotia) | 0.5–1× | Truffles; generally milder per gram |

Critical implication: A 3.5g dose of P. azurescens is roughly equivalent to 10–14g of standard cubensis. Never apply cubensis dose expectations to other species without adjusting dramatically downward.

Potency Variation Within Species

Even within a single species and cultivation batch, potency varies by:

• Individual fruiting body: Some mushrooms in the same flush are more potent than others
• Flush number: First and second flushes are generally most potent; later flushes may lose potency
• Storage conditions: Psilocybin degrades over time, particularly with exposure to light, moisture, and heat; properly dried and stored mushrooms retain potency much better
• Drying method: Overly high heat during drying degrades psilocybin; desiccant-based drying is preferred

Practical implication: Even with weight-based dosing, the same measured weight may produce different experiences from batch to batch. This is one argument for starting conservative on any new batch.

Synthetic Psilocybin vs. Mushrooms

Clinical trials almost universally use pharmaceutical-grade synthetic psilocybin (measured precisely in milligrams). When comparing clinical research to naturalistic use:

• 25mg synthetic psilocybin ≈ 3.5g dried cubensis (rough equivalence, varies)
• 10mg synthetic psilocybin ≈ 1.5g dried cubensis (rough equivalence)

The conversion is approximate because mushroom potency varies. In clinical contexts, synthetic psilocybin removes potency variability — a major advantage for research purposes and a significant safety advantage for clinical use.

First Session Recommendations

If using psilocybin for the first time:

1. Start at the low end of the low-dose range (1–1.5g dried cubensis equivalent)
2. Have a trusted, sober sitter present
3. Fast lightly (4 hours) before the session
4. Allow 6+ hours of unscheduled time
5. Have a comfortable, familiar private space
6. Do not combine with cannabis (which potentiates dramatically), alcohol (which is generally counterproductive), or other substances
7. Wait at least 4–6 weeks before repeating

The first session establishes your baseline sensitivity. This information is irreplaceable and not worth rushing.

Microdosing Doses

Microdosing is defined as sub-threshold doses — typically 1/10 to 1/20 of a moderate dose:

• Standard microdose range: 0.05–0.3g dried cubensis
• Most commonly reported effective range: 0.1–0.2g
• Protocol: Every 3rd day (Fadiman protocol) or 4 on / 3 off (Stamets stack) are common; avoid consecutive days to prevent tolerance

At proper microdose levels, there should be no perceptual alteration, no impairment, and no "high." If perceptible effects occur, the dose is likely in "mini-dose" territory (0.3–0.8g), which occupies an awkward middle zone many users find counterproductive.